RHHBF - AstraZeneca in pact with Absci to develop cancer drug based on AI
2023-12-04 07:49:22 ET
More on Absci, AstraZeneca, etc.
- AstraZeneca Pays Hefty Price For Chinese Weight-Loss Drug
- AstraZeneca PLC 2023 Q3 - Results - Earnings Call Presentation
- AstraZeneca PLC (AZN) Q3 2023 Earnings Call Transcript
- EU regulators seeking more info on GLP-1s and suicidal thoughts: report
- AstraZeneca pulls plug on anti-hyperkalaemia drug trials
For further details see:
AstraZeneca in pact with Absci to develop cancer drug based on AI